Advertisement
Screener

PRECISION OPTICS CORPORATION, INC. (POCI) Overview

PRECISION OPTICS CORPORATION, INC. (POCI) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.01; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -0.23; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.21; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.30; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$3.70$4.11$4.57$5.07$5.64$6.262025-11-062026-11-06$1.85$2.48$3.33$4.47$5.99$8.032021-11-082026-11-06$1.14$1.68$2.49$3.68$5.44$8.032016-11-072026-11-06$0.06$0.21$0.79$2.95$10.99$40.952006-11-062026-11-06$0.06$0.72$9.09$114.80$1,449.82$18,309.371992-01-162026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$4.91
Previous close
$4.27
Change
$0.64
Change (%)
14.87%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

POCI
+1.91%
S&P 500
(m)

1 year

POCI
-2.73%
S&P 500
(m)

3 years

POCI
-28.24%
S&P 500
(m)

5 years

POCI
-19.59%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual -0.01

-0.38-0.24-0.100.030.1731 Dec 2024: estimate (m); actual -0.1531 Dec 2024(m)31 Mar 2025: estimate (m); actual -0.3031 Mar 2025(m)30 Sept 2025: estimate (m); actual -0.2130 Sept 2025(m)31 Dec 2025: estimate (m); actual -0.2331 Dec 2025(m)31 Mar 2026: estimate (m); actual -0.0131 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)-0.01(m)(m)
1 Oct 202531 Dec 2025(m)-0.23(m)(m)
1 Jul 202530 Sept 2025(m)-0.21(m)(m)
1 Jan 202531 Mar 2025(m)-0.30(m)(m)
1 Oct 202431 Dec 2024(m)-0.15(m)(m)

30 Jun 2025 ○ Estimate (m) ● Actual -0.85

-0.93-0.66-0.38-0.100.1730 Jun 2021: estimate (m); actual -0.0130 Jun 2021(m)30 Jun 2022: estimate (m); actual -0.1830 Jun 2022(m)30 Jun 2023: estimate (m); actual -0.0330 Jun 2023(m)30 Jun 2024: estimate (m); actual -0.4930 Jun 2024(m)30 Jun 2025: estimate (m); actual -0.8530 Jun 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jul 202430 Jun 2025(m)-0.85(m)(m)
1 Jul 202330 Jun 2024(m)-0.49(m)(m)
1 Jul 202230 Jun 2023(m)-0.03(m)(m)
1 Jul 202130 Jun 2022(m)-0.18(m)(m)
1 Jul 202030 Jun 2021(m)-0.01(m)(m)

Revenue vs. Earnings

USD

31 Mar 2026 ■ Revenue 8.71M ■ Earnings -0.11M — Profit margin -1.24%

-3.39M-51.1%1.07M-34.1%5.54M-17.2%10.01M-0.2%31 Mar 2025: revenue 4.19M; earnings -2.10M; profit margin -50.09%31 Mar 202530 Sept 2025: revenue 6.68M; earnings -1.64M; profit margin -24.50%30 Sept 202531 Dec 2025: revenue 7.37M; earnings -1.78M; profit margin -24.17%31 Dec 202531 Mar 2026: revenue 8.71M; earnings -0.11M; profit margin -1.24%31 Mar 2026

30 Jun 2025 ■ Revenue 19.09M ■ Earnings -5.78M — Profit margin -30.28%

-9.00M-31.3%2.09M-20.7%13.18M-10.2%24.26M0.3%30 Jun 2022: revenue 15.68M; earnings -0.93M; profit margin -5.92%30 Jun 202230 Jun 2023: revenue 21.04M; earnings -0.14M; profit margin -0.69%30 Jun 202330 Jun 2024: revenue 19.10M; earnings -2.95M; profit margin -15.45%30 Jun 202430 Jun 2025: revenue 19.09M; earnings -5.78M; profit margin -30.28%30 Jun 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$4.91(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$4.91High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning POCI

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Mar 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-4.93M
Profit margin
-17.03%
Return on assets · 12 month
-18.49%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
76.61K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-6.97%*
Total return · month
-2.95%*
Total return · quarter
-16.76%*
Total return · half year
1.91%*
Total return · year to date
1.91%*
Total return · 1 year
-2.73%*
Total return · 3 years
-28.24%*
Total return · 5 years
-19.59%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$28.94M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
7.13%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

PRECISION OPTICS CORPORATION, INC. Overview

View more →

(m)

(m)

SEC CIK
867840
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Country of operation
United States
Business address
550 KING STREET,, BLDG. A, STE. 100, LITTLETON, Massachusetts, 01460, United States
Fiscal year end
0630
Phone
978-630-1800

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outset Medical, Inc. (OM)United States$0.059B-1.09
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
IRIDEX CORP (IRIX)United States$0.011B
Nexalin Technology, Inc. (NXL)United States$0.094B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Neuraxis, INC (NRXS)United States$0.097B
Nuwellis, Inc. (NUWE)United States$0.003B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B